Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
25 Sep 2023, 06:01
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product $ELTP
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product $ELTP
7 Sep 2023, 06:01
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer $ELTP
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer $ELTP
28 Aug 2023, 06:00
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study $ELTP
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study $ELTP
14 Aug 2023, 16:45
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information $ELTP
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information $ELTP
show more ▾
featured articles
April 18, 2024
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
Drilling Confirms 4 km of Favourable Corridor at Lynx Gold Trend $PUMA $PUXPF.US $PUMXF.US
April 18, 2024
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
Arizona Metals Intersects 20.1 m at 3.4% CuEq (incl. 3.2 m at 14.9% CuEq) and 38.0 m at 1.4% CuEq (incl. 4.4 m at 7.1% CuEq) in Kay Mine Expansion Drilling $AMC $AZMCF.US
April 17, 2024
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
WonderFi Appoints Jaime Leverton and Noel Biderman to its Board of Directors $WONDF.US $WNDR $52D0 $CA97818W1077
April 17, 2024
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
American Eagle's 2024 Exploration Program Underway $AMEGF.US $AE $CA02553R1073
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Elite Pharmaceuticals, Inc.
ELTP
$ELTP ↻
0 online
Today
This week
Search
Subscribe
Sign up to become a contributing member of the community.
Trending
Personal channels
